Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Expert Opinion on Drug Discovery
|
October 28, 2025
Harnessing antimalarial chemical space: the way forward
Sandeep Sundriyal, Animesh Majumdar
ACS Omega
|
March 15, 2021
Physicochemical Profiling and Comparison of Research Antiplasmodials and Advanced Stage Antimalarials with Oral Drugs
Amritansh Bhanot, Sandeep Sundriyal
European Journal of Medicinal Chemistry
|
December 11, 2020
Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective
Sharyu Kesharwani, Sandeep Sundriyal
European Journal of Medicinal Chemistry
|
May 2, 2008
'Sum of activities' as dependent parameter: a new CoMFA-based approach for the design of pan PPAR agonists
Sandeep Sundriyal, Prasad V Bharatam
Journal of Nanoscience and Nanotechnology
|
October 20, 2006
Molecular electrostatic potentials in the design of dendrimers for the delivery of glitazones
Prasad V Bharatam, Sandeep Sundriyal
European Journal of Medicinal Chemistry
|
March 10, 2009
Important pharmacophoric features of pan PPAR agonists: common chemical feature analysis and virtual screening
Sandeep Sundriyal, Prasad V Bharatam
Current Medicinal Chemistry
|
May 23, 2006
Current advances in antifungal targets and drug development
Sandeep Sundriyal, Rohit K Sharma, Rahul Jain
RSC Advances
|
January 17, 2025
Multicomponent reactions (MCRs) yielding medicinally relevant rings: a recent update and chemical space analysis of the scaffolds
Mukesh Tandi, Vaibhav Sharma, Balasubramanian Gopal, et al.
Bioorganic & Medicinal Chemistry
|
November 23, 2020
Tubulin inhibitory activity of a novel colchicine-binding compounds based on a dinaphthospiropyranran scaffold
Sandeep Sundriyal, Venkateswararao Eeda, Pallavi Lagisetty, et al.
RSC Advances
|
September 2, 2024
Design and synthesis of non-hydroxamate lipophilic inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): <i>in silico</i>, <i>in vitro</i> and antibacterial studies
Sharyu Kesharwani, Eeba, Mukesh Tandi, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Expert Opinion on Drug Discovery
|
October 28, 2025
Harnessing antimalarial chemical space: the way forward
Sandeep Sundriyal, Animesh Majumdar
ACS Omega
|
March 15, 2021
Physicochemical Profiling and Comparison of Research Antiplasmodials and Advanced Stage Antimalarials with Oral Drugs
Amritansh Bhanot, Sandeep Sundriyal
European Journal of Medicinal Chemistry
|
December 11, 2020
Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective
Sharyu Kesharwani, Sandeep Sundriyal
European Journal of Medicinal Chemistry
|
May 2, 2008
'Sum of activities' as dependent parameter: a new CoMFA-based approach for the design of pan PPAR agonists
Sandeep Sundriyal, Prasad V Bharatam
Journal of Nanoscience and Nanotechnology
|
October 20, 2006
Molecular electrostatic potentials in the design of dendrimers for the delivery of glitazones
Prasad V Bharatam, Sandeep Sundriyal
European Journal of Medicinal Chemistry
|
March 10, 2009
Important pharmacophoric features of pan PPAR agonists: common chemical feature analysis and virtual screening
Sandeep Sundriyal, Prasad V Bharatam
Current Medicinal Chemistry
|
May 23, 2006
Current advances in antifungal targets and drug development
Sandeep Sundriyal, Rohit K Sharma, Rahul Jain
RSC Advances
|
January 17, 2025
Multicomponent reactions (MCRs) yielding medicinally relevant rings: a recent update and chemical space analysis of the scaffolds
Mukesh Tandi, Vaibhav Sharma, Balasubramanian Gopal, et al.
Bioorganic & Medicinal Chemistry
|
November 23, 2020
Tubulin inhibitory activity of a novel colchicine-binding compounds based on a dinaphthospiropyranran scaffold
Sandeep Sundriyal, Venkateswararao Eeda, Pallavi Lagisetty, et al.
RSC Advances
|
September 2, 2024
Design and synthesis of non-hydroxamate lipophilic inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): <i>in silico</i>, <i>in vitro</i> and antibacterial studies
Sharyu Kesharwani, Eeba, Mukesh Tandi, et al.
Page
of 4